Trials / Completed
CompletedNCT06301919
Use of N-Butyl Cyanoacrylate in Transarterial Emergency Embolization
Use of N-Butyl Cyanoacrylate in Transarterial Emergency Embolization : a "Real-life" Retrospective Monocentric Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 122 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
NBCA is a synthetic biodegradable cyanoacrylate basis glue, modified by the addition of a monomer with adhesive, hemostatic, and antiseptic properties. Its use requires a steep learning curve to control emulsification of the NBCA/lipiodol mixture, and injection, to avoid non-target embolization. The aim of this retrospective monocentric study was to evaluate safety and efficacy of use of NBCA as embolic agent in emergency setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Clinical data | Collecting data from the medical record. |
| OTHER | Imaging data | Collecting data from the medical record. |
| OTHER | Biological data | Collecting data from the medical record. |
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2024-05-01
- Completion
- 2024-05-01
- First posted
- 2024-03-08
- Last updated
- 2025-01-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06301919. Inclusion in this directory is not an endorsement.